OPXBIO uses its pro­pri­etary, lead­ing EDGE™ (Effi­cien­cy Direct­ed Genome Engi­neer­ing) tech­nol­o­gy to man­u­fac­ture renew­able bio-based chem­i­cals and fuels that are low­er cost, high­er return and more sus­tain­able than exist­ing petro­le­um-based prod­ucts. In addi­tion to DBL Part­ners, investors include:X/Seed Cap­i­tal, USRG, Mohr Davi­d­ow, Brae­mar Ener­gy Ven­tures and Wolfen­sohn & Co.